The multiplex biomarker imaging market is projected to grow from USD 0.6 billion in 2025 to USD 1.6 billion by 2035, at a CAGR of 10.8%. Instruments will dominate with a 42.0% market share, while immunohistochemistry (ihc) assay will lead the imaging technique segment with a 44.0% share.